You just read:

Biohaven Receives Notice Of Allowance From U.S. Patent And Trademark Office On Patent Application For Glutamate Modulating Prodrugs

News provided by

Biohaven Pharmaceutical Holding Company Ltd.

Jul 13, 2017, 03:00 ET